Uploaded by houseofdiagnostics

Lu-177 PSMA Therapy Delhi NCR

advertisement
Prostate cancer is the most common form of cancer in men over the
age of 50. The most common reason for prostate cancer include
DNA changes (inherited or caused by exposure to radiation), chronic
inflammation, exposure to cancer-causing chemicals, high levels of
androgens, or insulin-like growth factor-1 (IGF-1). The therapy is
also known as theranostic, which combines therapy with
diagnostics. The concept behind this therapy is to make use of
radioactivity, which can damage and kill cancer cells without
indiscriminately attacking healthy cells in the body.
If you live in Delhi and want to know about “Lu-177 PSMA
therapy Delhi” then do an online search to know about the centres
offering this therapy.
Prostate cancer cells make a surface protein called PSMA (prostate
specific membrane antigen). The Lutetium-177 PSMA Therapy
combines targets advanced metastatic prostate cancer, using
Lutetium, which attaches to PSMA receptors on cancer cells through
specific molecules. Lutetium-177 releases beta rays and since it
binds to the tumour, it damages the cancer cells and spares the
surrounding healthy tissues. By targeting the molecules of PSMA,
the treatment becomes very precise as the Lutetium molecule binds
with the PSMA.
Lutetium-177 PSMA therapy cost will vary depending on the
location of the diagnostic centre.
Contact Us:
Address: 14, 15 & 16 Hargovind Enclave, Main Vikas Marg, New Delhi - 110092
Email Us: info@hod.care
Call Us: +91 9089089089
Download